Abnormal motor function and the expression of striatal dopamine D2 receptors in manganese-treated mice

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 10, 2008, Pages 1894-1897

  Nam, Jungmin ^a   Kim, Kisok ^a  

^a Keimyung University   (South Korea)

Author keywords

Dopamine receptor; Manganese; Motor activity; Neurotoxicity; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; MANGANESE; MESSENGER RNA; PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; LOW DRUG DOSE; MALE; METAL BINDING; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; DENSITOMETRY; DYSKINESIA, DRUG-INDUCED; MANGANESE POISONING; MICE; MICE, INBRED C57BL; MUSCULOSKELETAL EQUILIBRIUM; NEOSTRIATUM; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 53549127593     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1894     Document Type: Article

References (24)

1. Takeda A., Brain Res. Rev., 41, 79-87 (2003).
2. Aschner M., Aschner J. L., Neurosci. Biobehav. Rev., 15, 333-340 (1991).
3. Hearn A. S., Stroupe M. E., Cabelli D. E., Ramilo C. A., Luba I P., Tainer J. A., Nick H. S., Silverman D. N., Biochemistry, 42, 2781-2789 (2003).
4. Olanow C. W., Good P. E., Shinoth H., Hewitt K. A., Vingerhoets F., Snow B. J., Beal M. F., Calne D. B., Perl D. P., Neurology, 46, 492-498(1996).
5. Perl D. P., Olanow C. W., J. Neuropathol. Exp. Neurol., 66, 675-682 (2007).
6. Morello M., Zatta P., Zambenedetti P., Martorana A., D'Angelo V., Melchiorri G., Bernardi G., Sancesario G., Brain Res. Bull, 74, 406-415 (2007).
7. Vezér T., Kurunczi A., Náray M., Papp A., Nagymajtényi L., Am. J. Ind. Med, 50, 841-852 (2007).
8. Pihl R. O., Parks M., Science, 198, 204-206 (1977).
9. Tran T. T., Chowanadisai W., Crinella F. M., Chicz-DeMet A., Lönnerdal B., Neurotoxicology, 23, 635-643 (2002).
10. Missale C., Nash S. R., Robinson S. W., Jaber M., Caron M. G., Physiol. Rev., 78, 189-225 (1998).
11. Lachowicz J. E., Sibley D. R., Pharmacol. Toxicol., 81, 105-113 (1997).
12. Vallone D., Picetti R., Borrelli E., Neurol. Biobehav. Rev., 24, 125-132 (2000).
13. Fitsanakis V.A., Au C., Erikson K. M., Aschner M., Neurochem. Int., 48, 426-433 (2006).
14. Hirata Y., Suzuno H., Tsuruta T., Oh-Hashi K., Kiuchi K., Toxicology, 244, 249-256 (2008).
15. Chen M. K., Lee J. S., McGlothan J. L., Furukawa E., Adams R. J., Alexander M., Wong D. E., Guilarte T. R., Neurotoxicology, 27, 229-236 (2006).
16. Guilarte T. R., Chen M. K., McGlothan J. L., Verina T., Wong D. E., Zhou Y., Alexander M., Rohde C. A., Syversen T., Decamp E., Koser A. J., Fritz S., Gonczi H., Anderson D. W., Schneider J. S., Exp. Neurol., 202, 381-390 (2006).
17. Gwiazda R., Lucchini R., Smith D., J. Toxicol. Environ. Health A, 70, 594-605 (2007).
18. Erikson K. M., Dorman D. C., Lash L. H., Aschner M., Toxicol. Sci., 97, 459-466 (2007).
19. Eriksson H., Gillberg P., Aquilonius S., Hedstrom K., Heilbronn E., Arch. Toxicol., 66, 359-364 (1992).
20. Kessler K. R., Wunderlich G., Hefter H., Seitz R. J., Mov. Disord., 18, 217-218(2003).
21. Emilien G., Maloteaux J. M., Geurts M., Hoogenberg K., Cragg S., Pharmacol. Ther., 84, 133-156 (1999).
22. Erikson K. M., Jones B. C., Hess E. J., Zhang Q., Beard J. L., Pharmacol. Biochem. Behav., 69, 409-418 (2001).
23. Soiza-Reilly M., Fossati M., Ibarra G. R., Azcurra J. M., Brain Res., 1004, 217-221 (2004).
24. Calabresi P., Ammassari-Teule M., Gubellini P., Sancesario G., Morello M., Centonze D., Marfia G. A., Saulle E., Passino E., Picconi B., Bernardi G., Neurobiol. Dis., 8, 419-432 (2001).